TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
BLSM

BlossomHill Therapeutics, Inc.

Healthcare · Biotechnology

18.60$ -0.3% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

BlossomHill Therapeutics, Inc. (BLSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 124 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BLSM
Line item Q1 25 Q1 26 Q2 26
– 143 124
– 120 101
– 116 95
– 116 95
– 296 42
– 16 19
– 0.5 1.1
– 5.4 3.9
– -152 82
– -156 -180
29 29 27

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?